Search results for "infarct"

showing 10 items of 1223 documents

Usefulness of C-reactive protein and left ventricular function for risk assessment in survivors of acute myocardial infarction.

2004

The additional prognostic information provided by C-reactive protein (CRP) to parameters of left ventricular function in survivors of acute myocardial infarction (AMI) was investigated in 665 patients (326 with ST elevation and 339 with non-ST elevation). Cox multivariable analysis identified the following predictors of 6-month cardiac death: age (per 5 years hazard ratio [HR] 1.2, 95% confidence interval [CI] 1.1 to 1.4, p = 0.004), Killip class >I at presentation (HR 2.4, 95% CI 1.3 to 4.5, p = 0.0001), a reduced ejection fraction (per 5% HR 1.3, 95% CI 1.2 to 1.4, p = 0.0001), and greater CRP (per 5 mg/L HR 1.02, 95% CI 1.01 to 1.04, p = 0.02); the C-index of the model was 0.77 without a…

Malemedicine.medical_specialtyMyocardial InfarctionRisk AssessmentVentricular Dysfunction LeftPredictive Value of TestsInternal medicineMedicineHumansMyocardial infarctionKillip classAgedProportional Hazards ModelsEjection fractionChi-Square Distributionbiologybusiness.industryProportional hazards modelST elevationHazard ratioC-reactive proteinmedicine.diseasePrognosisConfidence intervalC-Reactive ProteinMultivariate AnalysisCardiologybiology.proteinFemaleCardiology and Cardiovascular MedicinebusinessBiomarkersFollow-Up StudiesThe American journal of cardiology
researchProduct

Myocarditis in Relation to Angiographic Findings in Patients With Provisional Diagnoses of MINOCA

2020

The aim of this study was to determine the prevalence of myocarditis among patients presenting with myocardial infarction with nonobstructive coronary arteries (MINOCA) in relation to the angiographic severity of nonobstructive coronary artery disease (CAD).MINOCA represents about 6% of all cases of acute myocardial infarction. Myocarditis is a diagnosis that may be identified by cardiac magnetic resonance (CMR) imaging in patients with a provisional diagnosis of MINOCA.A systematic review was performed to identify studies reporting the results of CMR findings in MINOCA patients with nonobstructive CAD or normal coronary arteries. Study-level and individual patient data meta-analyses were p…

Malemedicine.medical_specialtyMyocarditisMyocardial InfarctionCoronary Artery Disease030204 cardiovascular system & hematologyCoronary AngiographyArticle030218 nuclear medicine & medical imagingCoronary artery disease03 medical and health sciences0302 clinical medicineRisk FactorsPredictive Value of TestsInternal medicinemedicineHumansRadiology Nuclear Medicine and imagingIn patientcardiovascular diseasesMyocardial infarctionMedical diagnosisbusiness.industrymedicine.diseaseCoronary VesselsConfidence interval3. Good healthCoronary arteriesMyocarditismedicine.anatomical_structureCardiologyFemaleCardiology and Cardiovascular MedicinebusinessCardiac magnetic resonanceJACC: Cardiovascular Imaging
researchProduct

Prognostic implications of pericardial effusion in acute heart failure: Does size matter?

2015

Somedegreeofpericardialeffusion(PE)occurredinupto20%ofpa-tientswithheartfailure(HF)[1].Arecentstudyshowedthatinpatientswithchronicheartfailure(CHF),evenahemodynamicallyirrelevantPEwasassociated withincreasedriskofadverseevents [2,3]. Should thesefindings be extrapolated to patients with AHF? Moreover, the patho-physiology of such association remains to be determined. Thus, thisstudy sought to evaluate the association between PE and the risk of 1-year mortality in patients with AHF.Weincluded1827consecutivepatientsadmittedforAHFintheCar-diology department of a tertiary university hospital from January 2004to July 2013. Patients with a hemodynamically compromised PE wereexcluded (n = 16). In a…

Malemedicine.medical_specialtyMyocarditisPericardial effusionPericardial EffusionInternal medicinemedicine.arterymedicineHumansMyocardial infarctionMortalityAgedAged 80 and overHeart Failurebusiness.industryFurosemideMiddle Agedmedicine.diseasePrognosisCardiac surgeryBlood pressureHeart failurePulmonary arteryAcute DiseaseCardiologyFemaleCardiology and Cardiovascular Medicinebusinessmedicine.drugInternational journal of cardiology
researchProduct

Long-term prognostic value of a comprehensive assessment of cardiac magnetic resonance indexes after an ST-segment elevation myocardial infarction.

2013

Abstract Introduction and objectives A variety of cardiac magnetic resonance indexes predict mid-term prognosis in ST-segment elevation myocardial infarction patients. The extent of transmural necrosis permits simple and accurate prediction of systolic recovery. However, its long-term prognostic value beyond a comprehensive clinical and cardiac magnetic resonance evaluation is unknown. We hypothesized that a simple semiquantitative assessment of the extent of transmural necrosis is the best resonance index to predict long-term outcome soon after a first ST-segment elevation myocardial infarction. Methods One week after a first ST-segment elevation myocardial infarction we carried out a comp…

Malemedicine.medical_specialtyNecrosisMagnetic Resonance SpectroscopyMyocardial InfarctionCoronary AngiographyElectrocardiographyNecrosisPredictive Value of TestsInternal medicineEdemamedicineST segmentHumansMyocardial infarctionAgedEjection fractionbusiness.industryHazard ratioGeneral MedicineMiddle Agedmedicine.diseasePrognosisTreatment OutcomeHeart failureCardiologyFemalemedicine.symptombusinessMaceFollow-Up StudiesRevista espanola de cardiologia (English ed.)
researchProduct

Prognostic Value of Myocardial Ischemia and Necrosis in Depressed Left Ventricular Function: a Multicenter Stress Cardiac Magnetic Resonance Registry

2013

A B S T R A C T Introduction and objectives: The incremental prognostic value of inducible myocardial ischemia over necrosis derived by stress cardiac magnetic resonance in depressed left ventricular function is unknown. We determined the prognostic value of necrosis and ischemia in patients with depressed left ventricular function referred for dipyridamole stress perfusion magnetic resonance. Methods: In a multicenter registry using stress magnetic resonance, the presence ( 2 segments) of late enhancement and perfusion defects and their association with major events (cardiac death and nonfatal infarction) was determined. Results: In 391 patients, perfusion defect or late enhancement were p…

Malemedicine.medical_specialtyNecrosisMyocardial IschemiaIschemiaInfarctionNecrosisVentricular Dysfunction LeftInternal medicinemedicineHumansRegistriesStress Cardiac Magnetic Resonance ImagingAgedmedicine.diagnostic_testbusiness.industryMyocardiumHazard ratioMagnetic resonance imagingGeneral MedicinePrognosismedicine.diseaseMagnetic Resonance ImagingDipyridamoleCardiac Imaging TechniquesCardiologyFemalemedicine.symptombusinessPerfusionmedicine.drugRevista Española de Cardiología (English Edition)
researchProduct

Evolution of 5 cardiovascular magnetic resonance–derived viability indexes after reperfused myocardial infarction

2007

The objective of this study was to evaluate the simultaneous evolution of 5 cardiovascular magnetic resonance-derived myocardial viability indexes.We studied 72 patients with a first ST-elevation myocardial infarction and sustained TIMI 3 flow. In the first week and in the sixth month of the study, using cardiovascular magnetic resonance imaging, we determined wall thickening (WT) and the following viability indexes: wall thickness, WT with low-dose dobutamine, microvascular perfusion in first-pass imaging, microvascular obstruction in late-enhancement imaging, and transmural extent of necrosis.In 250 dysfunctional segments, the evolution outcomes for the viability indexes were as follows: …

Malemedicine.medical_specialtyNecrosisReperfused myocardial infarctionMyocardial InfarctionMyocardial ReperfusionInternal medicinemedicineHumansMyocardial infarctionmedicine.diagnostic_testbusiness.industryMagnetic resonance imagingMiddle Agedmedicine.diseaseMagnetic Resonance ImagingCirculatory systemCardiologyFemaleDobutaminemedicine.symptomCardiology and Cardiovascular MedicineWall thicknessNuclear medicinebusinessTIMImedicine.drugAmerican Heart Journal
researchProduct

Stroke after tadalafil use

2013

No abstract available

Malemedicine.medical_specialtyNeurologyStroke; tadalafil Phosphodiesterase inhibitorsDermatologyTadalafilInternal medicinemedicineHumansStrokeNeuroradiologymedicine.diagnostic_testCerebral infarctionbusiness.industrySettore MED/44 - Medicina Del LavoroBrainMagnetic resonance imagingGeneral MedicineMiddle AgedPhosphodiesterase 5 Inhibitorsmedicine.diseaseMagnetic Resonance ImagingTadalafilStrokePsychiatry and Mental healthSexual Dysfunction PhysiologicalSexual dysfunctionCardiologyNeurology (clinical)Neurosurgerymedicine.symptombusinesstadalafil Phosphodiesterase inhibitorsmedicine.drugCarbolines
researchProduct

Oxidative Inhibition of the Mitochondrial Aldehyde Dehydrogenase Promotes Nitroglycerin Tolerance in Human Blood Vessels

2007

Objectives We tested the hypothesis of whether an inhibition of the nitroglycerin (GTN) bioactivating enzyme mitochondrial aldehyde dehydrogenase (ALDH-2) contributes to GTN tolerance in human blood vessels. Background The hemodynamic effects of GTN are rapidly blunted by the development of tolerance, a phenomenon associated with increased formation of reactive oxygen species (ROS). Recent studies suggest that ROS-induced inhibition of ALDH-2 accounts for tolerance in animal models. Methods Segments of surgically removed arteria mammaria and vena saphena from patients undergoing coronary bypass surgery were used to examine the vascular responsiveness to GTN and the endothelium-dependent vas…

Malemedicine.medical_specialtyNitric Oxide Synthase Type IIIVasodilator AgentsMyocardial InfarctionAldehyde dehydrogenaseVasodilationPharmacologyDrug Administration ScheduleTissue Culture TechniquesNitroglycerinIn vivoEnosmedicineHumansSaphenous VeinEndothelial dysfunctionMammary ArteriesAgedbiologybusiness.industryAldehyde Dehydrogenase MitochondrialDrug ToleranceAldehyde Dehydrogenasemedicine.diseasebiology.organism_classificationAcetylcholineSurgeryOxidative Stressmedicine.anatomical_structureCirculatory systemcardiovascular systembiology.proteinFemaleAnimal studiesbusinessCardiology and Cardiovascular Medicinecirculatory and respiratory physiologyBlood vesselJournal of the American College of Cardiology
researchProduct

Sicilian DES Registry: prospective in-hospital and 9-month clinical and angiographic follow-up in selected high restenosis risk patients.

2008

OBJECTIVE: This is a multicentre, open label, prospective non-randomized registry, with 9-month angiographic follow-up, conducted to evaluate the safety and effectiveness of drug-eluting stents (DES) when used in high restenosis risk patients from the real world. METHODS: From June 2004 to February 2005, a total of 1622 consecutive patients were enrolled to the Sicilian DES Registry, according to specific inclusion criteria. Both paclitaxel-eluting and sirolimus-eluting stents were used. The analysis was performed on 1472 patients because 150 patients were excluded from the study. The primary endpoint was to evaluate the rate of major adverse cardiac events (MACE) within 9 months after DES …

Malemedicine.medical_specialtyPaclitaxelCoronary angioplastyRegistry.Target vessel revascularizationCoronary DiseaseCoronary AngiographyCoronary artery diseaseCoronary RestenosisRestenosisClinical endpointMedicineHumansCumulative incidencecardiovascular diseasesMyocardial infarctionDrug eluting stentRegistriesAngioplasty Balloon CoronarySicilyAgedSirolimusEjection fractionbusiness.industryIncidence (epidemiology)Drug-Eluting StentsGeneral MedicineMiddle Agedmedicine.diseaseSurgeryFemaleCardiology and Cardiovascular MedicinebusinessMaceDiabetic AngiopathiesImmunosuppressive AgentsJournal of cardiovascular medicine (Hagerstown, Md.)
researchProduct

Long-term clinical outcomes after drug-eluting stent implantation in unprotected left main coronary artery disease.

2009

Objective: To investigate long-term outcomes of unprotected left main coronary artery (ULMCA) disease treatment using drug-eluting stents (DES). Background: In several studies, DES implantation in ULMCA appeared safe and effective at mid-term; however, to date, there is limited long-term data. Methods: All consecutive patients undergoing sirolimus- or paclitaxel-eluting stent implantation in ULMCA disease at a single institution were evaluated. The primary endpoint was long-term major adverse cardiac events (MACE) defined as cardiac death, nonfatal myocardial infarction, or target lesion revascularization (TLR). Stent thrombosis (ST), according to Academic Research Consortium definitions, w…

Malemedicine.medical_specialtyPaclitaxelmedicine.medical_treatmentCoronary Artery DiseaseCoronary AngiographyRestenosisRecurrenceInternal medicineLong-term outcomes.medicineClinical endpointHumansRadiology Nuclear Medicine and imagingcardiovascular diseasesMyocardial infarctionSurvival rateAgedProportional Hazards ModelsSirolimusChi-Square Distributionbusiness.industryHazard ratioEuroSCOREDrug-Eluting StentsGeneral MedicineLeft main coronary arterymedicine.diseaseSurgeryTreatment OutcomeDrug-eluting stentCardiologyFemaleDrug-eluting stentCardiology and Cardiovascular MedicinebusinessMaceFollow-Up StudiesCatheterization and cardiovascular interventions : official journal of the Society for Cardiac AngiographyInterventions
researchProduct